NewsVoir Mumbai Maharashtra [India]2 Lung cancer remains one of the most prevalent and deadly cancers globally with approximately 22 million new cases diagnosed annually contributing to 18 of all canc ...

Japanese drugmaker Takeda (TYO: 4502) has launched Fruzaqla (fruquintinib) in its home country. This follows the approval of ...

Weill Cornell Medicine researchers have determined the full-length structure of a blood pressure-regulating hormone receptor ...

Researchers elucidated the molecular details of how Drosophila larval epidermal cells (LECs) undergo cell death in a controlled manner to regulate epithelial tissue remodeling. Specifically, lower ...

Takeda said in September 2024 that it received approval from the Japanese Ministry of Health, Labour and Welfare to manufacture and market FRUZAQLA Capsules 1mg/5mg, a selective oral inhibitor of ...

The study demonstrates that activating the vitamin D receptor (VDR) with calcitriol suppresses cell proliferation in ...

Researchers developed SNIPRs, innovative receptors that sense soluble ligands, enabling precise therapeutic control in CAR ...

Puma Biotechnology (PBYI) announced the initiation of its ALISertib in CAncer Phase II trial of alisertib in combination with endocrine therapy ...

A new study presents a customised treatment strategy using antisense oligonucleotides (ASOs) to target EGFR mutations in ...

In this trial, alisertib will be assessed in conjunction with endocrine therapy for treating individuals having hormone ...

Neoadjuvant immunotherapy offers a survival benefit in specific subtypes of patients but seems to offer no benefit in the ...